| Schedule of effect of the reverse recapitalization | |
| | |
| | |
| | |
| |
| | |
Number of
Shares | | |
Weighted-
Average
Exercise Price | | |
Weighted-Average
Remaining
Contractual Term
(Years) | | |
Aggregate
Intrinsic Value | |
| Balance at December 31, 2025 | |
| 67,299,982 | | |
$ | 4.31 | | |
| 3.97 | | |
$ | 65,096 | |
| Granted | |
| — | | |
| — | | |
| | | |
| | |
| Exercised | |
| — | | |
| — | | |
| | | |
| | |
| Forfeited and expired | |
| — | | |
| — | | |
| | | |
| | |
| Balance at March 31, 2026 | |
| 67,299,982 | | |
| 4.31 | | |
| 3.72 | | |
| 17,745 | |
| Warrants vested and exercisable at March 31, 2026 | |
| 66,399,982 | | |
$ | 4.31 | | |
| 3.72 | | |
$ | 17,367 | |